Minimizing the Pesky Placebo Response in IBS Trials

(MedPage Today) -- Pharmacological trials in irritable bowel syndrome (IBS) should include a run-in period of at least 2 weeks and dosing of no more than once or twice a day in order to minimize the pooled placebo response rate, a new meta-analysis...